Rank #1304LQDA

Liquidia Corporation

$35.05

0.26% (Daily)

Market Cap

$3.05B

Revenue

$69.22M

Rank by MCap

#1304

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Roger A. Jeffs Ph.D.

Headquarters

Morrisville, NC

Employees

170

About Liquidia Corporation

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutan...